Hypnotic Sedatives Flashcards
Sedative binding at allosteric site of the GABA-A receptor POTENTIATING GABA
Benzodiazepine
Ion channel of GABA A receptor causing less excitation and hyperpolarization
Chloride
Benzodiazepines effect promote hyperpolarization of chloride channels by
Increasing frequency of opening
Causes sedation, decrease in anxiety, calming effect, hypnosis and drowsiness
Benzodiazepine
Benzodiazepines are metabolized in the
liver
Short acting benzodiazepines (4)
Oxazepam
Trazolam
Alprazolam
Midazolam
Forms active metabolites increasing risk of toxicity for elderly and those with liver disease
t 1/2 100
2 drugs
Long acting benzodiazepams
Diazepam
Chlordiazepoxide
Has self tapering effect for alcohol withdrawal hence first line
Long acting Benzodiazepine
3 stages of withdrawal (alcohol)
8-12h after last dose: insomnia, tremulousness, anxiety, autonomic instability
12-48h : Seizure give BZD IV (status epilepticus, > 30 mins tonic/clonic) Diazepam or Lorazepam
48-96h : delirium tremens fever, agitation, disorientation
For patients with alcohol withdrawal and concomittant liver failure
Oxazepam
Lorazepam
Benzodiazepine treats (6)
1 Alcohol withdrawal 2 Anesthetic conscious sedation in minor operation 3 Insomnia (short term) 4 Parasomnia 5 Central muscle relaxant - spasticity 6 Acute Anxiety
BZD Adverse effects (2)
dose dependent effect on CNS impaired judgement drowsiness and central ataxia
Aterograde amnesia - conscious sedation
bzd Contraindication (2)
1 do not give with other hypnotics (alcohol, barbiturates, narcoleptic, 1st gen antihistamine)
2 elderly
Binds to GABA A receptor at an allosteric site but with shorter duration of action greater specificity, less anxiolysis and anti convulsant property
Zolpidem zaleplone eszopidone
Short duration of action non-bzd used for difficulty falling asleep or sleep onset insomnia
Zolpidem
Zaleplone
Used for sleep onset and maintenance insomnia longer half life 5-7 h
Eszopidone
Antidote for non BZD hypnotics
Flumazenil
Endogenous molecule by the brain regulating sleep cycle
Melatonin
Melatonin receptor agonist maintaining circadian rhythm
Ramelteon
Tazamelteon
Ramelteon and Tazamelteon MOA
agonist of MT1 and MT2 receptors at suprachiasmatic nucleus
Advantage of using melatonin receptors (4)
No rebound insomnia
No effect on sleep architecture
No withdrawal sx
No dose adjustment in elderly
Oldest antiseizure and sedative drug in critically ill
Barbiturates
Barbiturates MOA
Prolongs duration of opening of Chloride channels leading to potentiation of GABA A
ultra shortacting barbiturate for induction in intubation (<30 sec)
Lipid soluble
Crosses BBB
Thiopental
Thiopental MOA
Rapidly acting due to redistribution to skeletal muscles and adipose
Previous first line for seizure but benchmarked due to SE
1st line in neonates
Phenobarbital
Phenobarbital SE (2)
1 hypotension
2 respiratory depression
For seizure and essential tremors given together with propanlol
Primidone
Barbiturates are inducers of
increase metabolism of (2)
CYP450
warfarin
statin